Dr Appifani Williams, PHARMD is a
Pharmacist based in Metlakatla, Alaska. Dr Appifani Williams is licensed to practice in Florida (license number 49387) and her current practice location is
563 Brendible St, Metlakatla, Alaska. She can be reached at her office (for appointments etc.) via phone at
(907) 886-4748.
NPI number for Dr Appifani Williams is 1568706562 and her current mailing address is 599 Rice Ave, Union, South Carolina. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1568706562.
Healthcare Provider's Profile
| Full Name | Dr Appifani Williams |
|---|
| Gender | Female |
|---|
| Speciality | Pharmacist |
|---|
| Location | 563 Brendible St, Metlakatla, Alaska |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
|---|
NPI Data:
- NPI Number: 1568706562
- Provider Enumeration Date: 11/15/2012
- Last Update Date: 04/01/2024
Medical Identifiers
Medical identifiers for Dr Appifani Williams such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
|---|
| 1568706562 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
|---|
| 183500000X | Pharmacist | 13964 (South Carolina) | Secondary |
| 183500000X | Pharmacist | 49387 (Florida) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Appifani Williams is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
|---|
Dr Appifani Williams, PHARMD
599 Rice Ave,
Union, SC 29379-1840
Ph: (864) 427-7668 | Dr Appifani Williams, PHARMD
563 Brendible St,
Metlakatla, AK 99926
Ph: (907) 886-4748 |
Reviews and Comments